GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Satellos Bioscience Inc (TSX:MSCL) » Definitions » 12-1 Month Momentum %

Satellos Bioscience (TSX:MSCL) 12-1 Month Momentum % : 84.78% (As of Dec. 12, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Satellos Bioscience 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-12-12), Satellos Bioscience's 12-1 Month Momentum % is 84.78%.

The industry rank for Satellos Bioscience's 12-1 Month Momentum % or its related term are showing as below:

TSX:MSCL's 12-1 Month Momentum % is ranked better than
89.34% of 1445 companies
in the Biotechnology industry
Industry Median: -12.3 vs TSX:MSCL: 84.78

Competitive Comparison of Satellos Bioscience's 12-1 Month Momentum %

For the Biotechnology subindustry, Satellos Bioscience's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Satellos Bioscience's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Satellos Bioscience's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Satellos Bioscience's 12-1 Month Momentum % falls into.



Satellos Bioscience  (TSX:MSCL) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Satellos Bioscience  (TSX:MSCL) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Satellos Bioscience 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Satellos Bioscience's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Satellos Bioscience Business Description

Traded in Other Exchanges
Address
200 Bay Street, Suite 2800, Royal Bank Plaza, South Tower, Toronto, ON, CAN, M5J 2J1
Satellos Bioscience Inc is a regenerative medicine company a biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.

Satellos Bioscience Headlines

No Headlines